Neurofilament light is a treatment-responsive biomarker in CLN2 disease.
Ru Y, Corado C, Soon RK Jr, Melton AC, Harris A, Yu GK, Pryer N, Sinclair JR, Katz ML, Ajayi T, Jacoby D, Russell CB, Chandriani S.
Ru Y, et al.
Ann Clin Transl Neurol. 2019 Dec;6(12):2437-2447. doi: 10.1002/acn3.50942. Epub 2019 Dec 8.
Ann Clin Transl Neurol. 2019.
PMID: 31814335
Free PMC article.
Clinical Trial.